Literature DB >> 22119862

The NLRP3 inflammasome is active but not essential in endotoxin-induced uveitis.

Holly L Rosenzweig1, April Woods, Jenna S Clowers, Stephen R Planck, James T Rosenbaum.   

Abstract

OBJECTIVE: The inflammasome complex involving caspase-1 and nucleotide-binding domain, leucine-rich repeat containing protein (NLRP)3, also known as NALP3 or cryopyrin is important for host responses to microbial pathogens and several autoinflammatory diseases. We investigated the extent to which NLRP3 and caspase-1 control ocular interleukin (IL)-1β production and severity of uveitis (intraocular inflammatory disease) in an established, acute inflammatory uveitis model, endotoxin-induced uveitis (EIU).
METHODS: Expression of NLRP3, its adaptor molecule ASC, also known as PYCARD (PYD and CARD domain containing), and caspase-1 were examined by immunoblotting. IL-1β production was measured by enzyme-linked immunosorbent assay (ELISA). Using knockout mice, roles for caspase-1 and NLRP3 were examined in uveitis induced by intraocular injection of Escherichia coli lipopolysaccharide (LPS).
RESULTS: NLRP3, ASC, and caspase-1 proteins are constitutively expressed in eye tissue. During EIU, IL-1β protein production increases; this requires the presence of both caspase-1 and NLRP3. However, severity of EIU is not altered by deficiency in either caspase-1 or NLRP3, as assessed by both intravital microscopy and histology.
CONCLUSIONS: These data identify the importance of the NLRP3 inflammasome for IL-1β production in the eye, yet indicate that its participation in EIU is nonessential.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22119862      PMCID: PMC3335428          DOI: 10.1007/s00011-011-0404-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  40 in total

1.  The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity.

Authors:  Tammy M Martin; Zili Zhang; Paul Kurz; Carlos D Rosé; Hong Chen; Huiying Lu; Stephen R Planck; Michael P Davey; James T Rosenbaum
Journal:  Arthritis Rheum       Date:  2009-02

Review 2.  The inflammasomes: guardians of the body.

Authors:  Fabio Martinon; Annick Mayor; Jürg Tschopp
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

3.  NOD1 expression in the eye and functional contribution to IL-1beta-dependent ocular inflammation in mice.

Authors:  Holly L Rosenzweig; Kellen T Galster; Stephen R Planck; James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

Review 4.  Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.

Authors:  Raphaela Goldbach-Mansky; Daniel L Kastner
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

5.  Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome.

Authors:  Thornik Reimer; Michael H Shaw; Luigi Franchi; Cevayir Coban; Ken J Ishii; Shizuo Akira; Toshihiro Horii; Ana Rodriguez; Gabriel Núñez
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

Review 6.  NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens.

Authors:  Igor E Brodsky; Denise Monack
Journal:  Semin Immunol       Date:  2009-06-17       Impact factor: 11.130

7.  Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.

Authors:  Mihai G Netea; Claudia A Nold-Petry; Marcel F Nold; Leo A B Joosten; Bastian Opitz; Jonathan H M van der Meer; Frank L van de Veerdonk; Gerben Ferwerda; Bas Heinhuis; Isabel Devesa; C Joel Funk; Robert J Mason; Bart Jan Kullberg; Anna Rubartelli; Jos W M van der Meer; Charles A Dinarello
Journal:  Blood       Date:  2008-12-22       Impact factor: 22.113

8.  NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways.

Authors:  Stephen B Willingham; Irving C Allen; Daniel T Bergstralh; Willie June Brickey; Max Tze-Han Huang; Debra J Taxman; Joseph A Duncan; Jenny P-Y Ting
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

Review 9.  The caspase-1 inflammasome: a pilot of innate immune responses.

Authors:  Hong Bing Yu; B Brett Finlay
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

10.  The NALP3/Cryopyrin-inflammasome complex is expressed in LPS-induced ocular inflammation.

Authors:  José F González-Benítez; Marco A Juárez-Verdayes; Sandra Rodríguez-Martínez; Mario E Cancino-Diaz; Francisco García-Vázquez; Juan C Cancino-Diaz
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

View more
  4 in total

1.  Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation.

Authors:  Xiaoman Li; Xiaowu Gu; Timothy M Boyce; Min Zheng; Alaina M Reagan; Hui Qi; Nawajes Mandal; Alex W Cohen; Michelle C Callegan; Daniel J J Carr; Michael H Elliott
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

Review 2.  Modeling intraocular bacterial infections.

Authors:  Roger A Astley; Phillip S Coburn; Salai Madhumathi Parkunan; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2016-05-03       Impact factor: 21.198

3.  Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory response.

Authors:  Cristhian J Ildefonso; Henrique Jaime; Manas R Biswal; Shannon E Boye; Qiuhong Li; William W Hauswirth; Alfred S Lewin
Journal:  Mol Ther       Date:  2015-02-20       Impact factor: 11.454

Review 4.  Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases.

Authors:  Meini Chen; Rong Rong; Xiaobo Xia
Journal:  J Neuroinflammation       Date:  2022-07-14       Impact factor: 9.587

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.